Environmental factors, not genetics, is more likely the driver of the escalation of cancer prevalence for the last 80 years.
A recent article by Paul Shafer in Tradeoffs looks at a recent working paper of a randomized intervention designed to increase mask wearing in rural Bangladesh. Given that COVID-19 cases are back on the rise and vaccination rates remain low, the article also discusses what these findings might mean for the United States.
Vaccines are one of the most powerful weapons we have against preventable disease. The authors’ findings that DOSE HPV increased HPV vaccination rates is encouraging. Public health experts and clinicians must prioritize vaccine acceptance and uptake through a variety of approaches, including system-level education interventions.
Jamie Daw (@jamie_daw) and Adam Sacarny (@asacarny) are both Assistant Professors in the Department of Health Policy and Management at the Mailman School of Public
My wife and I were in Venice recently. You may have heard about the city’s crowds and the smell of stagnant water. Visit in January
The gold standard of medical research, the randomized controlled trial, has been taking a bit of a beating lately. An entire issue of the journal
As you know, I’m now the Web and Social Media Editor at JAMA Pediatrics. We’ve got a podcast where I discuss a paper from the journal.
Never disrespect the randomized controlled trial. This is Healthcare Triage News: @aaronecarroll
Just on Monday, we covered the difference between brand name and generic drugs. To be honest, we taped that episode a few weeks ago. It
We’ve already discussed drug names, generic and “brand” ones. But are there differences beyond the words? That’s the topic of this week’s HCT. For those
I need to cite this, but haven’t seen it appear anywhere else online. (Come on media!!!) From Jim Poterba, President of the National Bureau of Economic Research,
the health services research blog
Work posted here under copyright © of the authors • Details on the Site Policies page
